Estradiol increases apoptosis in human coronary artery endothelial cells by up-regulating fas and fas ligand expression

Creative Commons License

Seli E., Guzeloglu-Kayisli O., Cakmak H., Kayisli U. A., Selam B., Arici A.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.91, sa.12, ss.4995-5001, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 91 Sayı: 12
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1210/jc.2006-1225
  • Dergi Adı: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.4995-5001
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Context: In animal models, estrogen inhibits atherogenesis by inhibiting many of the early steps of atherosclerotic plaque formation. However, the lack of cardioprotective effect by postmenopausal hormone replacement therapy and possible increase in cardiovascular events observed during the first year after the initiation of hormone replacement therapy may suggest that once the plaque is formed, estrogen may have additional effects that may counteract its beneficial outcomes. Indeed, the effect of estrogen on plaque stability has not been identified.